SCHEMBL6852552

SCHEMBL6852552

OC[C@H]1O[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)ncnc32)C(O)C1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 3/20 1.00
ADORA2A P29274 2/20 1.00
ADORA1 P30542 2/20 1.00
ADORA2B P29275 1/20 1.00
SLC29A1 Q99808 2/20 0.77
TP53 P04637 1/20 0.77
TDP1 Q9NUW8 1/20 0.77
NFKB1 P19838 1/20 0.74
THPO P40225 1/20 0.74
TSHR P16473 1/20 0.74
LMNA P02545 2/20 0.73
ALDH1A1 P00352 1/20 0.73
GLA P06280 1/20 0.73
PMP22 Q01453 1/20 0.73
SMN1; SMN2 Q16637 1/20 0.73
NPC1 O15118 1/20 0.73
NPY1R P25929 1/20 0.73
HTT P42858 1/20 0.73
NPY2R P49146 1/20 0.73
RAB9A P51151 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6852543 1.00 ADORA3 (1.00) ADORA3ADORA2AADORA1ADORA2BSLC29A1
SCHEMBL10684309 0.94 ADORA3 (0.89) ADORA3ADORA2AADORA1ADORA2BSLC29A1
SCHEMBL10684302 0.94 ADORA3 (0.89) ADORA3ADORA2AADORA1ADORA2BSLC29A1
SCHEMBL10686730 0.94 ADORA3 (0.89) ADORA3ADORA2AADORA1ADORA2BSLC29A1
SCHEMBL10686723 0.94 ADORA3 (0.89) ADORA3ADORA2AADORA1ADORA2BSLC29A1
SCHEMBL10685562 0.93 ADORA3 (0.86) ADORA3ADORA2AADORA1ADORA2BSLC29A1
SCHEMBL10683942 0.93 ADORA2A (0.86) ADORA3ADORA2AADORA1ADORA2BTSHR
SCHEMBL10683936 0.93 ADORA2A (0.86) ADORA3ADORA2AADORA1ADORA2BTSHR
SCHEMBL10685557 0.93 ADORA3 (0.86) ADORA3ADORA2AADORA1ADORA2BSLC29A1
SCHEMBL4754960 0.92 ADORA3 (0.86) ADORA3ADORA2AADORA1ADORA2BSLC29A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0996453-B1 METHODS FOR THE INHIBITION OF NEURONAL ACTIVITY BY LOCAL DELIVERY OF ADENOSINE MOHLER HANNS (CH) 2004-04-28 EP claimed
EP-0139358-B1 N6-SUBSTITUTED DIARYLALKYL ADENOSINES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME WARNER-LAMBERT COMPANY (US) 1988-11-09 EP claimed
EP-0251339-A2 N6- substituted diarylalkyl adenosines, processes for their production and pharmaceutical compositions comprising the same WARNER-LAMBERT COMPANY (US) 1988-01-07 EP disclosed